A Study of Isoprinosine in Patients With Lymph Node Disease

Completed · Not applicable

Conditions studied: Lymphatic Disease, HIV Infections

In brief

The objectives of this study are to determine the effects of isoprinosine in patients diagnosed as having unexplained generalized lymphadenopathy. Variables to be examined will include: Signs and symptoms: * Lymphadenopathy. * Fever. * Weight loss. * Occurrence of opportunistic infections. Cell-mediated immune system parameters: * T-helper cell (OKT4) numbers and proportions. * T-suppressor cell (OKT8) numbers and proportions. * Natural killer (NK) cell activity. * Lymphocyte blastogenic response to phytohemagglutinin (PHA). * Lymphocyte blastogenic response to pokeweed mitogen (PWM). * Immunoglobulin (IgG, IgA, IgM, IgE, IgD) profile. * Circulating immune complexes. Infections characteristically associated with AIDS, such as Candida albicans, Pneumocystis carinii pneumonia, Cytomegalovirus, Herpes simplex, Cryptococcus, Histoplasma, Toxoplasma, Cryptosporidium, Mycobacterium avium- intracellulare, Legionella, and Isospora. Safety parameters: * Blood chemistry including serum uric acid (PurposeA-12). * Complete blood count (CBC). * Platelet count.

Key facts

Study ID
NCT00002297
Run by
Newport Pharmaceuticals International
Last updated by the study team
2005-06-24

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.